Online Inquiry
Cat.#: ACPP-1230
| Despition | MC3 Receptor Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1735 | Human BEST1 Protein (AC1735) | 5 µg | inquiry |
| ACPP-1307 | NPY2R Blocking Peptide (AC1307) | 250 µg | inquiry |
| ACPP-1802 | Human STAC Protein (AC1802) | 5 µg | inquiry |
| ACPP-1833 | Human CRMP1 Protein (AC1833) | 5 µg | inquiry |
| ACPP-1562 | Human TAGLN3 Protein (AC1562) | 5 µg | inquiry |
| ACPP-1632 | Mouse CTSB Protein (AC1632) | 2 µg | inquiry |
| ACPP-1484 | Human CPE Protein (AC1484) | 5 µg | inquiry |
| ACPP-1840 | Human ALDH1A1 Protein (AC1840) | 5 µg | inquiry |
| ACPP-1227 | Pax2 Blocking Peptide (AC1227) | 250 µg | inquiry |
| ACPP-1196 | Insulin Receptor beta Blocking Peptide (AC1196) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.